MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
Canada - TSX:MDA - CA55293N1096 - Common Stock
27.38 CAD
-1.56 (-5.39%)
We assign a fundamental rating of 6 out of 10 to MDA. MDA was compared to 11 industry peers in the Aerospace & Defense industry. While MDA has a great profitability rating, there are some minor concerns on its financial health. MDA is not overvalued while it is showing excellent growth. This is an interesting combination. This makes MDA very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year MDA was profitable.
MDA had a positive operating cash flow in the past year.
Of the past 5 years MDA 4 years were profitable.
Each year in the past 5 years MDA had a positive operating cash flow.
1.2 Ratios
MDA has a Return On Assets of 3.63%. This is amongst the best in the industry. MDA outperforms 90.91% of its industry peers.
MDA has a Return On Equity of 8.94%. This is amongst the best in the industry. MDA outperforms 100.00% of its industry peers.
MDA has a Return On Invested Capital (5.72%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for MDA is below the industry average of 8.31%.
The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROIC | 5.72% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
MDA has a Profit Margin of 8.48%. This is amongst the best in the industry. MDA outperforms 90.91% of its industry peers.
MDA's Profit Margin has improved in the last couple of years.
MDA's Operating Margin of 10.97% is in line compared to the rest of the industry. MDA outperforms 45.45% of its industry peers.
In the last couple of years the Operating Margin of MDA has grown nicely.
Looking at the Gross Margin, with a value of 24.54%, MDA is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Gross Margin of MDA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDA is destroying value.
MDA has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, MDA has an improved debt to assets ratio.
2.2 Solvency
MDA has an Altman-Z score of 1.77. This is a bad value and indicates that MDA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of MDA (1.77) is better than 81.82% of its industry peers.
MDA has a debt to FCF ratio of 0.55. This is a very positive value and a sign of high solvency as it would only need 0.55 years to pay back of all of its debts.
The Debt to FCF ratio of MDA (0.55) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.29 indicates that MDA is not too dependend on debt financing.
MDA's Debt to Equity ratio of 0.29 is amongst the best of the industry. MDA outperforms 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 1.77 |
ROIC/WACC0.65
WACC8.75%
2.3 Liquidity
A Current Ratio of 0.86 indicates that MDA may have some problems paying its short term obligations.
MDA's Current ratio of 0.86 is on the low side compared to the rest of the industry. MDA is outperformed by 81.82% of its industry peers.
MDA has a Quick Ratio of 0.86. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
MDA has a better Quick ratio (0.85) than 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 185.37% over the past year.
Measured over the past years, MDA shows a very strong growth in Earnings Per Share. The EPS has been growing by 185.75% on average per year.
MDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 57.21%.
MDA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.32% yearly.
EPS 1Y (TTM)185.37%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%322.22%
Revenue 1Y (TTM)57.21%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%54.26%
3.2 Future
Based on estimates for the next years, MDA will show a very strong growth in Earnings Per Share. The EPS will grow by 35.83% on average per year.
The Revenue is expected to grow by 23.54% on average over the next years. This is a very strong growth
EPS Next Y110.37%
EPS Next 2Y51.4%
EPS Next 3Y35.83%
EPS Next 5YN/A
Revenue Next Year52.26%
Revenue Next 2Y31%
Revenue Next 3Y23.54%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
MDA is valuated rather expensively with a Price/Earnings ratio of 23.40.
72.73% of the companies in the same industry are more expensive than MDA, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.10. MDA is around the same levels.
MDA is valuated rather expensively with a Price/Forward Earnings ratio of 17.06.
The rest of the industry has a similar Price/Forward Earnings ratio as MDA.
The average S&P500 Price/Forward Earnings ratio is at 22.52. MDA is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.4 | ||
| Fwd PE | 17.06 |
4.2 Price Multiples
MDA's Enterprise Value to EBITDA is on the same level as the industry average.
100.00% of the companies in the same industry are more expensive than MDA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.87 | ||
| EV/EBITDA | 13.77 |
4.3 Compensation for Growth
MDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MDA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as MDA's earnings are expected to grow with 35.83% in the coming years.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y51.4%
EPS Next 3Y35.83%
5. Dividend
5.1 Amount
No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:MDA (10/31/2025, 7:00:00 PM)
27.38
-1.56 (-5.39%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners32.56%
Inst Owner ChangeN/A
Ins Owners1.18%
Ins Owner ChangeN/A
Market Cap3.45B
Revenue(TTM)1.35B
Net Income(TTM)114.70M
Analysts78.18
Price Target44.43 (62.27%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.62%
Min EPS beat(2)21.08%
Max EPS beat(2)22.16%
EPS beat(4)4
Avg EPS beat(4)29.79%
Min EPS beat(4)19.18%
Max EPS beat(4)56.74%
EPS beat(8)7
Avg EPS beat(8)31.88%
EPS beat(12)11
Avg EPS beat(12)88.39%
EPS beat(16)14
Avg EPS beat(16)87.43%
Revenue beat(2)1
Avg Revenue beat(2)3.32%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)6.87%
Revenue beat(4)3
Avg Revenue beat(4)3.78%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)3.09%
Revenue beat(12)9
Avg Revenue beat(12)2.82%
Revenue beat(16)10
Avg Revenue beat(16)0.84%
PT rev (1m)0.67%
PT rev (3m)14.67%
EPS NQ rev (1m)-3.18%
EPS NQ rev (3m)-6.03%
EPS NY rev (1m)0%
EPS NY rev (3m)23.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.53%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)1.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.4 | ||
| Fwd PE | 17.06 | ||
| P/S | 2.55 | ||
| P/FCF | 4.87 | ||
| P/OCF | 3.59 | ||
| P/B | 2.69 | ||
| P/tB | 13.6 | ||
| EV/EBITDA | 13.77 |
EPS(TTM)1.17
EY4.27%
EPS(NY)1.6
Fwd EY5.86%
FCF(TTM)5.62
FCFY20.52%
OCF(TTM)7.63
OCFY27.86%
SpS10.73
BVpS10.17
TBVpS2.01
PEG (NY)0.21
PEG (5Y)N/A
Graham Number16.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROCE | 7.95% | ||
| ROIC | 5.72% | ||
| ROICexc | 8.9% | ||
| ROICexgc | 61.78% | ||
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% | ||
| FCFM | 52.35% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Debt/EBITDA | 1.52 | ||
| Cap/Depr | 262.11% | ||
| Cap/Sales | 18.71% | ||
| Interest Coverage | 8.48 | ||
| Cash Conversion | 392.53% | ||
| Profit Quality | 617.7% | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 1.77 |
F-Score6
WACC8.75%
ROIC/WACC0.65
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.37%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%322.22%
EPS Next Y110.37%
EPS Next 2Y51.4%
EPS Next 3Y35.83%
EPS Next 5YN/A
Revenue 1Y (TTM)57.21%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%54.26%
Revenue Next Year52.26%
Revenue Next 2Y31%
Revenue Next 3Y23.54%
Revenue Next 5YN/A
EBIT growth 1Y115.07%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year179.33%
EBIT Next 3Y51.75%
EBIT Next 5YN/A
FCF growth 1Y1778.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y628.56%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 6 / 10 to MDA.CA.
What is the valuation status for MDA stock?
ChartMill assigns a valuation rating of 6 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Fairly Valued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 7 / 10.
What is the valuation of MDA SPACE LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for MDA SPACE LTD (MDA.CA) is 23.4 and the Price/Book (PB) ratio is 2.69.